CopyFind

IBRANCE 125 MG CAPSULAS DURAS

Analogs of IBRANCE 125 MG CAPSULAS DURAS

Find cheaper analogs and generic equivalents for IBRANCE 125 MG CAPSULAS DURAS.

Ingredients

सक्रिय अवयव: PALBOCICLIB

Inactive Ingredients: LACTOSA MONOHIDRATO 92.958 mg


उत्पाद अवलोकन

About IBRANCE 125 MG CAPSULAS DURAS

IBRANCE 125 MG CAPSULAS DURAS is a prescription medication that contains the active ingredient palbociclib. It is formulated as hard capsules designed for oral administration. The product is intended for use in the treatment of certain types of breast cancer in adult patients. The capsules are manufactured under strict quality control standards to ensure consistent potency and safety. Patients should follow the dosage instructions provided by their healthcare professional and should not exceed the prescribed amount. The medication is supplied in a blister pack that protects the capsules from moisture and light. Proper storage conditions are recommended to maintain the integrity of the product. The formulation is free from common allergens such as gluten and dairy, making it suitable for a wide range of patients. The product is available only through a licensed pharmacy and requires a valid prescription for purchase.

Key Benefits & Uses

  • Provides targeted therapy for hormone receptor–positive, HER2-negative breast cancer.
  • Administered orally, allowing convenient self‑administration at home.
  • Designed to be used in combination with endocrine therapy to enhance treatment efficacy.

Active Ingredient & Action

Palbociclib is a selective cyclin‑dependent kinase 4/6 inhibitor that interferes with the cell cycle in cancer cells, thereby slowing tumor growth and proliferation. By blocking the activity of CDK4/6, the drug prevents the phosphorylation of the retinoblastoma protein, which is essential for the transition from the G1 to the S phase of the cell cycle. This mechanism of action helps to control the progression of certain breast cancers that rely on estrogen signaling for growth.

Important Notes

Patients should be monitored regularly for blood cell counts and liver function while on therapy. Palbociclib may interact with other medications, so a comprehensive medication review is essential before starting treatment. The medication should be taken with food to improve absorption. Patients should avoid exposure to high levels of radiation and inform their healthcare provider of any new symptoms. The product is not intended for use in children or adolescents. For detailed prescribing information, consult the product label or a qualified healthcare professional.

Visitor ratings

Help others by rating how useful this product page is.

No ratings yet — be the first.